Pages that link to "Q46959718"
Jump to navigation
Jump to search
The following pages link to Could HTR2A T102C and DRD3 Ser9Gly predict clinical improvement in patients with acutely exacerbated schizophrenia? Results from treatment responses to risperidone in a naturalistic setting (Q46959718):
Displaying 19 items.
- Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia (Q28248687) (← links)
- Pharmacogenetics of antipsychotics (Q33836837) (← links)
- Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction (Q34676533) (← links)
- The promise and reality of pharmacogenetics in psychiatry (Q35226451) (← links)
- Association of common genetic variants with risperidone adverse events in a Spanish schizophrenic population (Q36747019) (← links)
- The potential role of dopamine D₃ receptor neurotransmission in cognition. (Q37106827) (← links)
- Use of combinatorial pharmacogenomic testing in two cases from community psychiatry (Q37194299) (← links)
- Review: The biological basis of antipsychotic response in schizophrenia (Q37638930) (← links)
- Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms (Q37678047) (← links)
- Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment (Q37711124) (← links)
- Pharmacogenetics of response to antipsychotics in patients with schizophrenia (Q37952823) (← links)
- Toward understanding genetic risk for differential antipsychotic response in individuals with schizophrenia (Q37960512) (← links)
- Pharmacogenetics of clinical response to risperidone. (Q38074712) (← links)
- Individualizing clozapine and risperidone treatment for schizophrenia patients (Q38170458) (← links)
- Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia. (Q46006540) (← links)
- HTR2A A-1438G/T102C polymorphisms predict negative symptoms performance upon aripiprazole treatment in schizophrenic patients. (Q46040000) (← links)
- The Promise and Reality of Pharmacogenetics in Psychiatry (Q51846528) (← links)
- Effect of polymorphisms on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers (Q57212204) (← links)
- Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients (Q95937928) (← links)